Supplementary Figure S2 from Association of Antifolate Response Signature Status and Clinical Activity of Pemetrexed-Platinum Chemotherapy in Non–Small Cell Lung Cancer: The Piedmont Study

Supplementary Figure S2 from Association of Antifolate Response Signature Status and Clinical Activity of Pemetrexed-Platinum Chemotherapy in Non–Small Cell Lung Cancer: The Piedmont Study

<p>Expression of Genes Associated with Antifolate (Pemetrexed) Activity by LUAD Subtype.</p>

Saved in:
Bibliographic Details
Main Author: Joel R. Eisner (15132120) (author)
Other Authors: Gregory M. Mayhew (16461959) (author), James M. Davison (16461962) (author), Kirk D. Beebe (15132123) (author), Yoichiro Shibata (16461965) (author), Yuelong Guo (15132126) (author), Carol Farhangfar (15132129) (author), Farhang Farhangfar (16461968) (author), Joshua M. Uronis (16461971) (author), Jeffrey M. Conroy (11092309) (author), Michael V. Milburn (16461974) (author), David Neil Hayes (15031908) (author), Kathryn F. Mileham (16461977) (author)
Published: 2025
Subjects:
Cancer
Cancer Detection and Diagnosis
Therapeutic Research and Development
Clinical Research and Trials
Methods and Technology
Biomarkers
Diagnostic biomarkers
Computational Methods
Gene expression profiling
Lung Cancer
Precision Medicine
Translational Research
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items